Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhibition of Carboxylesterase Metabolism by Ethanol

NCT01708369 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.

NCT NCT01708369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01708369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhibition of Carboxylesterase Metabolism by Ethanol
Lead sponsor
University of Tennessee
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2012
Completion date
May 31, 2012
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug interactions